Intuitive Surgical, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- David J. Rosa
- Full Time Employees
- 17,021
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 1020 Kifer Road Sunnyvale CA United States 94086-5304
- IPO Date
- Jun 13, 2000
- CIK
- 0001035267
- Website
- intuitive.com
- Similar Companies
- Business
- Intuitive Surgical, Inc. develops, manufactures, and markets advanced robotic-assisted surgical systems designed to enhance the quality and access to minimally invasive care globally. Its core products include the da Vinci Surgical System, which enables surgeons to perform a wide range of complex surgical procedures across specialties such as general surgery, urology, gynecology, cardiothoracic, and head and neck surgery using minimally invasive techniques. The company also offers the Ion Endoluminal System, a robotic platform for diagnostic endoluminal procedures enabling minimally invasive lung biopsies through advanced imaging and navigation technology. Intuitive’s product suite includes stapling, energy, and core instrumentation compatible with its multi-port da Vinci systems, alongside progressive learning pathways that facilitate clinical adoption, and a comprehensive infrastructure of service and support including installation, maintenance, technical support, proactive system health monitoring, and integrated digital capabilities that provide hospitals with data-driven insights to optimize surgical performance. Founded in 1995 and headquartered in Sunnyvale, California, Intuitive Surgical operates globally, supporting hospitals and surgical teams across over 60 countries. In the last 1-2 years, the company has advanced the commercial launch of its da Vinci 5 Surgical System, receiving regulatory clearances from the US FDA and CE mark in 2024, with 2025 focused on scaling the adoption of this platform through enhanced hardware and software upgrades featuring increased computing power and digital capabilities. Intuitive reported significant growth in system placements and procedure volumes, with a 14% year-over-year increase in installed base and 17% procedural growth as of mid-2025. Strategic priorities include expanding its robotic surgery ecosystem, reinforcing its recurring revenue model—which accounted for 84% of revenue in 2024—and furthering its Quintuple Aim framework aimed at improving patient outcomes, care team experience, access to care, and lowering total costs. Additionally, leadership transitioned in mid-2025 with President Dave Rosa promoted to CEO, signaling a new phase of growth and innovation focus. Despite rising competition in the robotic surgery field, Intuitive remains a dominant market leader through continuous technological innovation and strategic expansion. This comprehensive offering positions Intuitive Surgical as a pioneer and global leader in robotic-assisted, minimally invasive surgical technology, serving healthcare providers with products, services, and digital innovations that collectively enhance surgical precision, patient recovery, and overall healthcare system efficiency.
Company News
Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Momentum Stock
Intuitive Appoints Aaron Martin to its Board of Directors
Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?
ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?
Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Growth Stock
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
Intuitive Surgical (NASDAQ:ISRG) VP Fredrik Widman Sells 4,047 Shares of Stock
Intuitive Surgical (NASDAQ:ISRG) Director Craig Barratt Sells 1,150 Shares of Stock
Intuitive Surgical (NASDAQ:ISRG) SVP Patricia Wadors Sells 1,078 Shares of Company Stock
Intuitive Surgical (NASDAQ:ISRG) Director Gary Guthart Sells 20,095 Shares of Company Stock
2,095 Intuitive Surgical, Inc. $ISRG Shares Sold by Evergreen Capital Management LLC
Intuitive Surgical (ISRG) is an Incredible Growth Stock: 3 Reasons Why
Earnings Estimates Moving Higher for Intuitive Surgical (ISRG): Time to Buy?
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Boomfish Wealth Group LLC Buys 2,900 Shares of Intuitive Surgical, Inc. $ISRG
New Strong Buy Stocks for October 23rd
Intuitive Surgical, Inc. $ISRG Shares Sold by Cadinha & Co. LLC
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story